Characterization of the genomic structure and function of regions influencing renin and angiogenesis in the SS rat

Physiological Genomics

Volumn 43, Issue 13, 2011, Pages 808-817

  Stodola, Timothy J ^a   de Resende, Micheline M ^c   Sarkis, Allison B ^a   Didier, Daniela N ^a,b   Jacob, Howard J ^a   Huebner, Norbert ^d   Hummel, Oliver ^d   Saar, Kathrin ^d   Moreno, Carol ^a   Greene, Andrew S ^a,b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b Department of Biotechnology and Bioengineering Center ^*  (United States)

^c TEXAS HEART INSTITUTE   (United States)

^d MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

Congenic; Consomic; Physiological genomics; Renin angiotensin system

Indexed keywords

LOSARTAN; RENIN;

ALLELE; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONGENIC STRAIN; CONTROLLED STUDY; DAHL SALT SENSITIVE RAT; ELECTROSTIMULATION; GENE STRUCTURE; GENETIC REGULATION; GENETIC VARIABILITY; GENOMICS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TIBIALIS ANTERIOR MUSCLE;

ANIMALS; ANIMALS, CONGENIC; BODY WEIGHT; CHROMOSOMES, MAMMALIAN; ELECTRIC STIMULATION; EXONS; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; GENOME; IMMUNOHISTOCHEMISTRY; MUSCLE, SKELETAL; NEOVASCULARIZATION, PHYSIOLOGIC; ORGAN SIZE; RATS; RATS, INBRED DAHL; RENIN; RNA, MESSENGER;

RATTUS;

EID: 79960356319     PISSN: 10948341     EISSN: 15312267     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00171.2010     Document Type: Article

References (67)

1. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions, and congestive heart failure. The SOLVD Investigators. N Engl J Med 325: 293-302, 1991.
2. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The CONSENSUS Trial Study Group. N Engl J Med 316: 1429-1435, 1987.
3. Amaral SL, Linderman JR, Morse MM, Greene AS. Angiogenesis induced by electrical stimulation is mediated by angiotensin II and VEGF. Microcirculation 8: 57-67, 2001.
4. Amaral SL, Papanek PE, Greene AS. Angiotensin II and VEGF are involved in angiogenesis induced by short-term exercise training. Am J Physiol Heart Circ Physiol 281: H1163-H1169, 2001.
5. Amaral SL, Roman RJ, Greene AS. Renin gene transfer restores angiogenesis and vascular endothelial growth factor expression in Dahl S rats. Hypertension 37: 386-390, 2001.
6. Atanur SS, Birol I, Guryev V, Hirst M, Hummel O, Morrissey C, Behmoaras J, Fernandez-Suarez XM, Johnson MD, McLaren WM, Patone G, Petretto E, Plessy C, Rockland KS, Rockland C, Saar K, Zhao Y, Carninci P, Flicek P, Kurtz T, Cuppen E, Pravenec M, Hubner N, Jones SJ, Birney E, Aitman TJ. The genome sequence of the spontaneously hypertensive rat: analysis and functional significance. Genome Res 20: 791-803, 2010.
7. Birnie DH, Gollob M, Healey JS. Clinical trials, the renin angiotensin system and atrial fibrillation. Curr Opin Cardiol 21: 368 -375, 2006.
8. Borensztein P, Germain S, Fuchs S, Philippe J, Corvol P, Pinet F. cis-regulatory elements and trans-acting factors directing basal and cAMPstimulated human renin gene expression in chorionic cells. Circ Res 74: 764-773, 1994.
9. Boudier HA. Arteriolar and capillary remodelling in hypertension. Drugs 58, Spec No 1: 37-40, 1999.
10. Buraczynska M, Pijanowski Z, Spasiewicz D, Nowicka T, Sodolski T, Widomska-Czekajska T, Ksiazek A. Renin-angiotensin system gene polymorphisms: assessment of the risk of coronary heart disease. Kardiol Pol 58: 1-9, 2003.
11. Campese VM. Salt sensitivity in hypertension. Renal and cardiovascular implications. Hypertension 23: 531-550, 1994.
12. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 407: 249-257, 2000.
13. Cowley AW, Jr, Roman RJ. The role of the kidney in hypertension. JAMA 275: 1581-1589, 1996.
14. de Resende MM, Amaral SL, Moreno C, Greene AS. Congenic strains reveal the effect of the renin gene on skeletal muscle angiogenesis induced by electrical stimulation. Physiol Genomics 33: 33-40, 2008.
15. de Resende MM, Amaral SL, Munzenmaier DH, Greene AS. Role of endothelial cell apoptosis in regulation of skeletal muscle angiogenesis during high and low salt intake. Physiol Genomics 25: 325-335, 2006.
16. de Resende MM, Greene AS. Effect of ANG II on endothelial cell apoptosis and survival and its impact on skeletal muscle angiogenesis after electrical stimulation. Am J Physiol Heart Circ Physiol 294: H2814- H2821, 2008.
17. de Resende MM, Stodola TJ, Greene AS. Role of the renin angiotensin system on bone marrow-derived stem cell function and its impact on skeletal muscle angiogenesis. Physiol Genomics 42: 437-444.
18. Doulton TW, He FJ, MacGregor GA. Systematic review of combined angiotensin-converting enzyme inhibition and angiotensin receptor blockade in hypertension. Hypertension 45: 880-886, 2005.
19. Emanueli C, Salis MB, Stacca T, Pinna A, Gaspa L, Madeddu P. Angiotensin AT(1) receptor signalling modulates reparative angiogenesis induced by limb ischaemia. Br J Pharmacol 135: 87-92, 2002.
20. Feldman HI, Klag MJ, Chiapella AP, Whelton PK. End-stage renal disease in US minority groups. Am J Kidney Dis 19: 397-410, 1992.
21. Ferrer-Martinez A, Montell E, Montori-Grau M, Garcia-Martinez C, Gomez-Foix AM, Roberts MA, Mansourian R, Mace K. Long-term cultured human myotubes decrease contractile gene expression and regulate apoptosis-related genes. Gene 384: 145-153, 2006.
22. Fogo A, Yoshida Y, Yared A, Ichikawa I. Importance of angiogenic action of angiotensin II in the glomerular growth of maturing kidneys. Kidney Int 38: 1068-1074, 1990.
23. Friedman RC, Farh KK, Burge CB, Bartel DP. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19: 92-105, 2009.
24. Fukuda S, Yoshii S, Kaga S, Matsumoto M, Kugiyama K, Maulik N. Angiogenic strategy for human ischemic heart disease: brief overview. Mol Cell Biochem 264: 143-149, 2004.
25. Gordon D, Abajian C, Green P. Consed: a graphical tool for sequence finishing. Genome Res 8: 195-202, 1998.
26. Grim CE, Wilson TW, Nicholson GD, Hassell TA, Fraser HS, Grim CM, Wilson DM. Blood pressure in blacks. Twin studies in Barbados. Hypertension 15: 803-809, 1990.
27. Hikichi T, Mori F, Takamiya A, Sasaki M, Horikawa Y, Takeda M, Yoshida A. Inhibitory effect of losartan on laser-induced choroidal neovascularization in rats. Am J Ophthalmol 132: 587-589, 2001.
28. Jensen LJ, Kuhn M, Stark M, Chaffron S, Creevey C, Muller J, Doerks T, Julien P, Roth A, Simonovic M, Bork P, von Mering C. STRING 8-a global view on proteins and their functional interactions in 630 organisms. Nucl Acids Res 37: D412-D416, 2009.
29. Kanehisa M, Goto S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res 28: 27-30, 2000.
30. Kang DH, Anderson S, Kim YG, Mazzalli M, Suga S, Jefferson JA, Gordon KL, Oyama TT, Hughes J, Hugo C, Kerjaschki D, Schreiner GF, Johnson RJ. Impaired angiogenesis in the aging kidney: vascular endothelial growth factor and thrombospondin-1 in renal disease. Am J Kidney Dis 37: 601-611, 2001.
31. Knoll KE, Pietrusz JL, Liang M. Tissue-specific transcriptome responses in rats with early streptozotocin-induced diabetes. Physiol Genomics 21: 222-229, 2005.
32. Krupinski J, Kaluza J, Kumar P, Kumar S, Wang JM. Role of angiogenesis in patients with cerebral ischemic stroke. Stroke 25: 1794-1798, 1994.
33. Kuzmanic D, Laganovic M, Dika Z, Kos J, Pecin I. [Antihypertensive agents and the risk of new onset diabetes mellitus]. Lijec Vjesn 128: 336-341, 2006.
34. Lackland DT, Keil JE. Epidemiology of hypertension in African Americans. Semin Nephrol 16: 63-70, 1996.
35. Le Noble FA, Hekking JW, Van Straaten HW, Slaaf DW, Struyker Boudier HA. Angiotensin II stimulates angiogenesis in the chorio-allantoic membrane of the chick embryo. Eur J Pharmacol 195: 305-306, 1991.
36. Li Q, Muragaki Y, Ueno H, Ooshima A. Stretch-induced proliferation of cultured vascular smooth muscle cells and a possible involvement of local renin-angiotensin system and platelet-derived growth factor (PDGF). Hypertens Res 20: 217-223, 1997.
37. Liang M, Yuan B, Rute E, Greene AS, Olivier M, Cowley AW, Jr. Insights into Dahl salt-sensitive hypertension revealed by temporal patterns of renal medullary gene expression. Physiol Genomics 12: 229-237, 2003.
38. Linderman JR, Kloehn MR, Greene AS. Development of an implantable muscle stimulator: measurement of stimulated angiogenesis and poststimulus vessel regression. Microcirculation 7: 119-128, 2000.
39. MacKinnon M, Shurraw S, Akbari A, Knoll GA, Jaffey J, Clark HD. Combination therapy with an angiotensin receptor blocker and an ACE inhibitor in proteinuric renal disease: a systematic review of the efficacy and safety data. Am J Kidney Dis 48: 8-20, 2006.
40. Molteni A, Heffelfinger S, Moulder JE, Uhal B, Castellani WJ. Potential deployment of angiotensin I converting enzyme inhibitors and of angiotensin II type 1 and type 2 receptor blockers in cancer chemotherapy. Anticancer Agents Med Chem 6: 451-460, 2006.
41. Moreno C, Hoffman M, Stodola TJ, Didier DN, Lazar J, Geurts AM, North PE, Jacob HJ, Greene AS. Creation and characterization of a renin knockout rat. Hypertension 57: 614-619, 2011.
42. Moreno C, Kaldunski ML, Wang T, Roman RJ, Greene AS, Lazar J, Jacob HJ, Cowley AW,Jr. Multiple blood pressure loci on rat chromosome 13 attenuate development of hypertension in the Dahl S hypertensive rat. Physiol Genomics 31: 228-235, 2007.
43. Munk VC, Sanchez de Miguel L, Petrimpol M, Butz N, Banfi A, Eriksson U, Hein L, Humar R, Battegay EJ. Angiotensin II induces angiogenesis in the hypoxic adult mouse heart in vitro through an AT2-B2 receptor pathway. Hypertension 49: 1178-1185, 2007.
44. Munzenmaier DH, Greene AS. Opposing actions of angiotensin II on microvascular growth and arterial blood pressure. Hypertension 27: 760-765, 1996.
45. Ng PC, Henikoff S. Predicting deleterious amino acid substitutions. Genome Res 11: 863-874, 2001.
46. Oosthuyse B, Moons L, Storkebaum E, Beck H, Nuyens D, Brusselmans K, Van Dorpe J, Hellings P, Gorselink M, Heymans S, Theilmeier G, Dewerchin M, Laudenbach V, Vermylen P, Raat H, Acker T, Vleminckx V, Van Den Bosch L, Cashman N, Fujisawa H, Drost MR, Sciot R, Bruyninckx F, Hicklin DJ, Ince C, Gressens P, Lupu F, Plate KH, Robberecht W, Herbert JM, Collen D, Carmeliet P. Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat Genet 28: 131-138, 2001.
47. Otani A, Takagi H, Suzuma K, Honda Y. Angiotensin II potentiates vascular endothelial growth factor-induced angiogenic activity in retinal microcapillary endothelial cells. Circ Res 82: 619-628, 1998.
48. Pan L, Gross KW. Transcriptional regulation of renin: an update. Hypertension 45: 3-8, 2005.
49. Pershadsingh HA. Treating the metabolic syndrome using angiotensin receptor antagonists that selectively modulate peroxisome proliferatoractivated receptor-gamma. Int J Biochem Cell Biol 38: 766-781, 2006.
50. Petersen MC, Greene AS. Angiotensin II is a critical mediator of prazosin-induced angiogenesis in skeletal muscle. Microcirculation 14: 583-591, 2007.
51. Petersen MC, Munzenmaier DH, Greene AS. Angiotensin II infusion restores stimulated angiogenesis in the skeletal muscle of rats on a high-salt diet. Am J Physiol Heart Circ Physiol 291: H114-H120, 2006.
52. Ramensky V, Bork P, Sunyaev S. Human non-synonymous SNPs: server and survey. Nucleic Acids Res 30: 3894-3900, 2002.
53. Rieder MJ, O'Drobinak DM, Greene AS. A computerized method for determination of microvascular density. Microvasc Res 49: 180-189, 1995.
54. Ritthaler T, Schricker K, Kees F, Kramer B, Kurtz A. Acute hypoxia stimulates renin secretion and renin gene expression in vivo but not in vitro. Am J Physiol Regul Integr Comp Physiol 272: R1105-R1111, 1997.
55. Ryan MJ, Black TA, Gross KW, Hajduczok G. Cyclic mechanical distension regulates renin gene transcription in As4.1 cells. Am J Physiol Endocrinol Metab 279: E830-E837, 2000.
56. Santos CF, Akashi AE, Dionisio TJ, Sipert CR, Didier DN, Greene AS, Oliveira SH, Pereira HJ, Becari C, Oliveira EB, Salgado MC. Characterization of a local renin-angiotensin system in rat gingival tissue. J Periodontol 80: 130-139, 2009.
57. Sekuri C, Cam FS, Ercan E, Tengiz I, Sagcan A, Eser E, Berdeli A, Akin M. Renin-angiotensin system gene polymorphisms and premature coronary heart disease. J Renin Angiotensin Aldosterone Syst 6: 38-42, 2005.
58. 2+ and voltage-activated potassium channels. J Pharmacol Exp Ther 330: 727-735, 2009.
59. Su AI, Wiltshire T, Batalov S, Lapp H, Ching KA, Block D, Zhang J, Soden R, Hayakawa M, Kreiman G, Cooke MP, Walker JR, Hogenesch JB. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci USA 101: 6062-6067, 2004.
60. Tian Z, Greene AS, Usa K, Matus IR, Bauwens J, Pietrusz JL, Cowley AW, Jr, Liang M. Renal regional proteomes in young Dahl salt-sensitive rats. Hypertension 51: 899-904, 2008.
61. Toko H, Zou Y, Minamino T, Masaya M, Harada M, Nagai T, Sugaya T, Terasaki F, Kitaura Y, Komuro I. Angiotensin II type 1a receptor is involved in cell infiltration, cytokine production, and neovascularization in infarcted myocardium. Arterioscler Thromb Vasc Biol 24: 664-670, 2004.
62. Van Belle E, Rivard A, Chen D, Silver M, Bunting S, Ferrara N, Symes JF, Bauters C, Isner JM. Hypercholesterolemia attenuates angiogenesis but does not preclude augmentation by angiogenic cytokines. Circulation 96: 2667-2674, 1997.
63. Vicencio AG, Chupp GL, Tsirilakis K, He X, Kessel A, Nandalike K, Veler H, Kipperman S, Young MC, Goldman DL. CHIT1 mutations: genetic risk factor for severe asthma with fungal sensitization? Pediatrics 126: e982-e985, 2010.
64. Waltenberger J. Impaired collateral vessel development in diabetes: potential cellular mechanisms and therapeutic implications. Cardiovasc Res 49: 554-560, 2001.
65. Wang SM, Rapp JP. Structural differences in the renin gene of Dahl salt-sensitive and salt-resistant rats. Mol Endocrinol 3: 288-294, 1989.
66. Wu C, Orozco C, Boyer J, Leglise M, Goodale J, Batalov S, Hodge CL, Haase J, Janes J, Huss JW, 3rd, Su AI. BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources. Genome Biol 10: R130, 2009.
67. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 342: 145-153, 2000.